「regulatory」の検索結果

Generates complete comorbidity-oriented shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Use when a study links two clinically related diseases through shared DEGs, enrichment, PPI hub genes, machine-learning feature selection, public diagnostic validation, gene-regulatory networks, immune infiltration, and optional downstream follow-up. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, machine-learning biomarker selection, immune/regulatory interpretation, multi-layer validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete cross-disease shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Always use this skill whenever a user wants to design, plan, or build a multi-dataset study linking two related diseases through shared DEGs, enrichment, PPI hub genes, public validation, regulatory-network analysis, immune infiltration, drug-gene interaction screening, and optional qRT-PCR or cell-line validation. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, regulatory-network interpretation, immune/drug follow-up, bioinformatics-plus-validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete process-related diagnostic biomarker bioinformatics research designs from a user-provided disease context, gene-family or pathway theme, and validation direction. Use when a study centers on process-related genes, DEG and WGCNA integration, machine-learning feature selection, nomogram-based diagnostic modeling, immune infiltration, regulatory-network analysis, and optional external or experimental validation. Covers five study patterns (process-DEG discovery, co-expression-module integration, machine-learning biomarker selection, diagnostic model/nomogram workflow, immune-regulatory interpretation and validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.

日本語の概要は準備中です。原文の説明を表示しています。

Use this bioinformatics data analysis skill to construct a database-driven lncRNA-mRNA regulatory network from target lncRNA and/or gene lists by projecting shared miRNA evidence from local ceRNA reference tables. It does not infer networks from expression matrices.

日本語の概要は準備中です。原文の説明を表示しています。

Use when writing or verifying the institutional / accounting-standard / regulatory background for a 《会计研究》 (Accounting Research) manuscript — getting standard clauses, regulatory rules, and effective dates exactly right, since precise institutional detail is a defining bar of this journal. Use before measurement and identification.

日本語の概要は準備中です。原文の説明を表示しています。

Use when the empirical identification strategy is the bottleneck for a 《会计研究》 (Accounting Research) manuscript — exogenous standard / regulatory changes (event study, DID), PSM, Heckman, IV — and you need to stress-test the design before drafting tables. Prefers standard/regulatory shocks as the cleanest accounting identification source.

日本語の概要は準備中です。原文の説明を表示しています。

Compare gene co-expression and regulatory networks between biological conditions to find rewired relationships using DiffCorr, DiffCoEx, DINGO/iDINGO, and CoDiNA. Covers the differential-connectivity-is-not-differential-expression distinction, the pairwise multiple-testing explosion, marginal vs partial (direct) rewiring, and the underpowered-rewiring failure mode. Use when comparing co-expression networks between disease vs control, treatment, or developmental stages, or finding hub genes that rewire without changing mean expression. For single-condition modules see coexpression-networks; for differential expression of means see differential-expression/de-results.

日本語の概要は準備中です。原文の説明を表示しています。

Annotate CLIP-seq peaks or crosslink sites to RNA features (5'UTR, CDS, 3'UTR, intron, splice junction, snoRNA, tRNA, ncRNA, repeat elements) with ChIPseeker, RCAS, RBP-Maps (Yeo splicing regulatory maps), and bedtools, applying feature-priority hierarchies, transcript-context resolution, and metagene aggregation. Use when characterizing where in transcripts an RBP binds, comparing peak distribution across regions, generating splicing-regulatory maps relative to alternative-splicing events, or distinguishing exonic vs intronic vs UTR binding.

日本語の概要は準備中です。原文の説明を表示しています。

Detects allele-specific transcription factor or histone modification binding from heterozygous-variant ChIP-seq using WASP (reference-bias filter; mandatory upstream), RASQUAL (joint QTL + bias-corrected testing), BaalChIP (Bayesian beta-binomial with copy-number-aware overdispersion), and AlleleSeq (personalized diploid genome). Handles imprinted-locus awareness, X-inactivation artifacts, cancer copy-number imbalance, and integration with downstream caQTL / bQTL mapping. Use when identifying variants with allelic effects on TF binding, fine-mapping causal regulatory variants, validating deep-learning variant predictions, or characterizing cis-acting regulatory effects.

日本語の概要は準備中です。原文の説明を表示しています。

Identifies super-enhancers from H3K27ac, MED1, or BRD4 ChIP-seq using ROSE, ROSE2, LILY, HOMER -style super, and ENCODE dELS cross-referencing. Handles peak stitching parameters, ranking choices, hockey-stick inflection, marker choice (H3K27ac vs MED1/BRD4), and cross-condition comparison with spike-in normalization. Constructs core regulatory circuitry (Saint-Andre 2016) from SE-encoded TFs. Use when identifying cell-identity / cancer-associated regulatory domains, comparing super-enhancers between conditions, identifying master transcription factor networks, or predicting BET-inhibitor responsiveness.

日本語の概要は準備中です。原文の説明を表示しています。

Predict enhancer-gene regulatory connections from ATAC-seq using ABC, ENCODE-rE2G, HiChIP, or Cicero. Use when linking distal enhancers to target genes, choosing between contact-aware (ABC, ENCODE-rE2G), accessibility-only (Cicero), and orthogonal (HiChIP H3K27ac, EpiMap) approaches, validating predictions against CRISPRi-FlowFISH gold-standard, or building cell-type-specific regulatory maps for fine-mapping or therapeutic target discovery.

日本語の概要は準備中です。原文の説明を表示しています。

EU AI Act Knowledge Engine — authoritative regulatory Q&A grounded in 70 official EU source documents (including the 2026 Commission draft guidelines on Art. 6 high-risk classification — general principles, Annex I, Annex III). Answers any question about the AI Act with article-level citations from the full regulation text, Commission guidelines, EDPB/EDPS opinions, codes of practice, harmonised standards, FRIA guides, incident templates, and sector-specific guidance. This skill should be used when the user asks about the "EU AI Act", "AI Act regulation", "Regulation 2024/1689", "KI-Verordnung", asks to "explain an AI Act article", "what does Article X say", "AI Act requirements", "AI Act penalties", "AI Act timeline", "GPAI obligations", "high-risk AI", "prohibited AI practices", "AI Act and GDPR", "fundamental rights impact assessment", "AI Act standards", "AI Act national implementation", "AI literacy", "serious incident reporting", "Digital Omnibus", "AI regulatory sandbox", or any question about EU artificial intelligence regulation. Also triggers on German terms: "KI-Gesetz", "KI-Verordnung", "Hochrisiko-KI", "KI-Kompetenz", "Grundrechte-Folgenabschaetzung", "GPAI-Verhaltenskodex". For assessment workflows that produce a classification decision rather than a knowledge answer, offer to run a structured risk-tier classification in-session.

日本語の概要は準備中です。原文の説明を表示しています。

A jurisdiction-grounding reference file for AI assistants working on Gibraltar legal, regulatory, and compliance research. Corrects systematic errors AI models make when applying English law to Gibraltar — a distinct jurisdiction under the Gibraltar Constitution Order 2006, with its own court hierarchy, civil procedure rules, employment law, and regulatory framework. Covers the source hierarchy, court structure, civil procedure divergences (14-day deemed service, post-Jackson reforms not adopted), employment law specifics (uncapped discrimination awards, 5-employee redundancy threshold), FSC financial services regulation, AML/KYC compliance sources, Gibraltar Companies Act 2014 with UBO public register, and a structured directory of official public record sources. Includes research profiles for lawyers, compliance professionals, and due diligence practitioners. Not legal advice.

日本語の概要は準備中です。原文の説明を表示しています。

Your legal, IP, and regulatory brain trust. 31 named personas across 7 cells covering patent strategy, tech licensing, regulatory litigation, AI governance, open-source compliance, privacy law, and antitrust.

日本語の概要は準備中です。原文の説明を表示しています。

[STUB] Regulatory report generation including IRS Form 8949, Schedule D, FinCEN FBAR, and state-specific crypto reporting requirements

日本語の概要は準備中です。原文の説明を表示しています。

Query openFDA API for drugs, devices, adverse events, recalls, regulatory submissions (510k, PMA), substance identification (UNII), for FDA regulatory data analysis and safety research.

日本語の概要は準備中です。原文の説明を表示しています。

Enterprise-grade compliance architecture for SOC 2, HIPAA, GDPR, PCI-DSS. Provides compliance checklists, security controls, audit guidance, and regulatory requirements for serverless and cloud architectures. Activates for compliance, HIPAA, SOC2, SOC 2, GDPR, PCI-DSS, PCI DSS, regulatory, healthcare data, payment card, data protection, audit, security standards, regulated industry, BAA, business associate agreement, DPIA, data protection impact assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Infer gene regulatory networks (GRNs) from gene expression data using scalable algorithms (GRNBoost2, GENIE3). Use when analyzing transcriptomics data (bulk RNA-seq, single-cell RNA-seq) to identify transcription factor-target gene relationships and regulatory interactions. Supports distributed computation for large-scale datasets.

日本語の概要は準備中です。原文の説明を表示しています。

JASPAR 2024 TF binding profiles via REST API and pyJASPAR. Retrieve PFMs/PWMs by TF name, JASPAR ID, species, or structural class. Scan DNA for TFBS; browse by taxon (human, mouse) or TF family (bHLH, zinc finger). Use for motif enrichment input, TFBS scanning, and regulatory sequence analysis. For ChIP-seq peak motif discovery use homer-motif-analysis; for regulatory variant scoring use regulomedb-database.

日本語の概要は準備中です。原文の説明を表示しています。

Track regulatory compliance for construction projects. Monitor permits, certifications, inspections, and regulatory requirements with automated alerts and reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Compares PIA/DPIA methodologies: CNIL PIA tool, ICO DPIA template, NIST Privacy Framework, and ISO 29134. Provides methodology selection criteria based on regulatory jurisdiction, organisation maturity, processing complexity, and resource availability. Covers regulatory acceptance, tool features, and cross-methodology mapping. Keywords: PIA methodology, CNIL, ICO, NIST Privacy Framework, ISO 29134, DPIA comparison, assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Predict enhancer-gene regulatory connections from ATAC-seq using ABC, ENCODE-rE2G, HiChIP, or Cicero. Use when linking distal enhancers to target genes, choosing between contact-aware (ABC, ENCODE-rE2G), accessibility-only (Cicero), and orthogonal (HiChIP H3K27ac, EpiMap) approaches, validating predictions against CRISPRi-FlowFISH gold-standard, or building cell-type-specific regulatory maps for fine-mapping or therapeutic target discovery.

日本語の概要は準備中です。原文の説明を表示しています。

Detects allele-specific transcription factor or histone modification binding from heterozygous-variant ChIP-seq using WASP (reference-bias filter; mandatory upstream), RASQUAL (joint QTL + bias-corrected testing), BaalChIP (Bayesian beta-binomial with copy-number-aware overdispersion), and AlleleSeq (personalized diploid genome). Handles imprinted-locus awareness, X-inactivation artifacts, cancer copy-number imbalance, and integration with downstream caQTL / bQTL mapping. Use when identifying variants with allelic effects on TF binding, fine-mapping causal regulatory variants, validating deep-learning variant predictions, or characterizing cis-acting regulatory effects.

日本語の概要は準備中です。原文の説明を表示しています。